Moss Genomics Inc., based in Vancouver, has successfully completed a private placement, raising $250,000 by selling 2.5 million common shares at $0.10 each. Alongside this, the company has acquired 160 Ethereum (ETH), issuing nearly 7.84 million shares in the process. Both transactions are pending final approval from the Canadian Securities Exchange. The funds will be used for general working capital. Additionally, Moss has appointed Hunter Jordan to its Board of Directors, who brings experience from a private real estate firm. The company also granted 200,000 stock options to various directors and consultants. Moss Genomics focuses on innovative healthcare solutions using AI and genomics while integrating blockchain technology.
Moss Genomics Inc. Closes Private Placement and Expands Blockchain Ventures
Vancouver, British Columbia – Moss Genomics Inc. has successfully completed its non-brokered private placement, issuing 2,500,000 common shares at $0.10 each, generating a total of $250,000. This strategic move is designed to support the company’s financial position as it ventures further into the biotech sector.
In addition to the private placement, Moss Genomics has made a significant investment in the cryptocurrency space, acquiring 160 Ethereum (ETH) through the issuance of 7,840,000 common shares. This acquisition reflects the company’s commitment to integrating blockchain technology alongside its innovative healthcare solutions.
The successful funding is subject to final acceptance from the Canadian Securities Exchange. All securities issued will have a statutory hold period of four months plus one day from their closing date.
Using Proceeds Wisely
The funds from both the private placement and ETH acquisition will be directed towards general working capital. This is a crucial step for Moss Genomics as it aims to fuel ongoing projects and expand its footprint in the growing biotech and cryptocurrency landscapes.
Leadership Update
Moss Genomics is also pleased to announce the appointment of Hunter Jordan to its Board of Directors. With a rich background in global real estate investments and strategic initiatives, Hunter brings valuable expertise to the team. His experience began at PwC, where he earned his CPA designation, and he has since worked across various sectors, positioning him well to contribute to Moss Genomics’ goals.
Stock Option Grants
In another important move, Moss Genomics has awarded a total of 200,000 stock options to directors, officers, and consultants, allowing them to purchase shares at an exercise price of $0.20 for a period of five years. This initiative is aimed at aligning the interests of the leadership team with the company’s growth trajectory.
About Moss Genomics Inc.
Moss Genomics is at the forefront of biotechnology, utilizing AI, genomic data, and diverse health insights to create groundbreaking health solutions. The company’s approach integrates modern blockchain advancements, establishing a strong foundation for innovation in the life sciences sector.
For more information, visit the Moss Genomics website or check out their SEDAR profile. With this strong financial backing, Moss Genomics is poised to make strides in both biotechnology and cryptocurrency, leading the way towards innovative health solutions.
What is Moss Genomics’ recent financial news?
Moss Genomics has completed a private placement, which means they raised money by selling shares to investors. They also bought 160 Ethereum cryptocurrency, which is a digital form of money.
Why did Moss Genomics buy Ethereum?
Moss Genomics bought Ethereum to support its growth and to invest in cryptocurrency. This could help the company explore new opportunities in the digital finance world.
Who is Hunter Jordan?
Hunter Jordan is a new member of Moss Genomics’ Board of Directors. He brings experience and expertise that can help guide the company’s future plans.
What does this mean for Moss Genomics?
This move shows that Moss Genomics is serious about expanding its business and taking advantage of new technologies like cryptocurrency. It can also attract more investors.
How can I stay updated on Moss Genomics?
You can follow Moss Genomics’ news on their website or through their official social media channels for the latest updates about their projects and developments.
